Fate
Develops off-the-shelf iPSC-derived CAR T and CAR NK therapies for autoimmune disease and cancer.
$2.43
After-hours close+0.01 (+0.60%)
At close$2.42(−4.92%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 61.93%72.19M sharesInsiders 19.92%23.22M sharesOther 18.15%21.16M shares
Shares outstanding 116.56M · Float —
Float — provider float is below the insider stake.
The provider's float is smaller than the insider stake it should exclude, so it is not shown.
Institutions13F, as of Jun 30, 2026
161 holders · 72.19M shares · 33 new positions · 88 increased · 38 reduced · 34 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Redmile Group, LLC | 12.87M | 11.04% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 7.30M | 6.26% | −2.77M | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 4.55M | 3.90% | +411.3K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 4.45M | 3.81% | +253.5K | Aug 13, 2026 |
| Acadian Asset Management LLC | 4.35M | 3.73% | +231.1K | Aug 13, 2026 |
| AQR Capital Management LLC | 3.84M | 3.29% | +835.7K | Aug 14, 2026 |
| Two Sigma Investments, LP | 3.59M | 3.08% | +123.1K | Aug 14, 2026 |
| Johnson & Johnson | 3.38M | 2.90% | 0 | Aug 6, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Redmile Group, LLCincl. RedCo II Master Fund, L.P., Jeremy C. Green +1 more | 14.90% | 18.23M | 13D | Apr 22, 2026 ↗ |
| BlackRock, Inc. | 6.90% | 7.85M | 13G | Apr 23, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Redmile Group, LLC | director, 10 percent owner: | 12.88M | 11.05% | Apr 22, 2026 |
| RedCo II Master Fund, L.P. | director, 10 percent owner: | 8.98M | 7.70% | Jul 3, 2025 |
| Bahram Valamehr | director, officer: President and CEO | 591.8K | 0.51% | Aug 5, 2026 |
| Cindy Tahl | officer: See Remarks | 589.4K | 0.51% | Aug 5, 2026 |
| Kamal Adawi | officer: Chief Financial Officer | 100.0K | 0.09% | Jan 16, 2026 |
| Robert S. Epstein | director | 36.3K | 0.03% | May 6, 2026 |
| William H. Rastetter | director | 36.3K | 0.03% | May 6, 2026 |
4 ten-percent owners hold 3.79M shares by Form 4 — the 13D/G table above shows those stakes, the figure above counts officers and directors only · 21 people have not refiled in the last 18 months (2.94M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 4, 2026 | Bahram Valamehrdirector, officer: President and CEO | Sale | 43,947 | $2.46 | 591,815 |
| Aug 4, 2026 | Cindy Tahlofficer: See Remarks | Sale | 38,800 | $2.46 | 589,355 |
| May 20, 2026 | Bahram Valamehrdirector, officer: President and CEO | Sale | 28,946 | $1.88 | 635,762 |
| May 20, 2026 | Cindy Tahlofficer: See Remarks | Sale | 25,590 | $1.88 | 628,155 |
| Jan 9, 2026 | Bahram Valamehrdirector, officer: President and CEO | Sale | 5,190 | $1.07 | 329,708 |
| Jan 9, 2026 | Cindy Tahlofficer: See Remarks | Sale | 10,589 | $1.06 | 387,081 |
CongressHouse and Senate disclosures
Not reported.